Know Cancer

or
forgot password

Improving Pain Management in Cancer Care


N/A
18 Years
N/A
Not Enrolling
Both
Pain, Unspecified Adult Solid Tumor, Protocol Specific

Thank you

Trial Information

Improving Pain Management in Cancer Care


OBJECTIVES:

- Develop and test a pain assessment and management system for people with cancer
(PAMS-PC).

- Obtain feedback from patients with non-hematologic malignancies on the proposed
features of the system and its usability and effectiveness.

OUTLINE: This is a multicenter study. The study contains 3 parts. Patients in part II are
assigned to 1 of 2 assessment groups.

- Part I: Patients participate in a focus interview by telephone over approximately 45
minutes. The interview includes discussion of beliefs and concerns regarding pain and
its management, strategies used by the patient for managing pain, the features of the
proposed pain assessment and management system for people with cancer (PAMS-PC), and
reactions of the patients to each proposed component of the system.

- Part II:

- Group A: Patients participate in an assessment session over approximately 90
minutes, comprising completion of a questionnaire followed by use of a test
version of the PAMS-PC.

- Group B: Patients use the PAMS-PC first followed by completion of the
questionnaire.

Thirty patients are then randomly selected from the 2 groups to repeat use of the PAMS-PC 3
hours after the initial assessment.

- Part III: Patients participate in a patient acceptance test over 30-60 minutes, in
which patients test the demo version of the system, complete an evaluation
questionnaire, and provide feedback by telephone.

PROJECTED ACCRUAL: A total of 180 patients (10 for part I, 150 (75 per group) for part II,
and 20 for part III) will be accrued for this study.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Diagnosis of non-hematologic cancer

PATIENT CHARACTERISTICS:

Age:

- 18 and over

Performance status:

- Not specified

Life expectancy:

- Not specified

Hematopoietic:

- Not specified

Hepatic:

- Not specified

Renal:

- Not specified

PRIOR CONCURRENT THERAPY:

Biologic therapy:

- Not specified

Chemotherapy:

- Not specified

Endocrine therapy:

- Not specified

Radiotherapy:

- Not specified

Surgery:

- Not specified

Type of Study:

Interventional

Study Design:

N/A

Principal Investigator

Michael Sean Davis, PhD

Investigator Role:

Study Chair

Investigator Affiliation:

Inflexxion, Inc.

Authority:

United States: Federal Government

Study ID:

CDR0000069327

NCT ID:

NCT00036829

Start Date:

March 2002

Completion Date:

Related Keywords:

  • Pain
  • Unspecified Adult Solid Tumor, Protocol Specific
  • unspecified adult solid tumor, protocol specific
  • pain

Name

Location

InflexxionNewton, Massachusetts  02464-1594